Today's Information

Provided by: Tanvex BioPharma, Inc.
SEQ_NO 1 Date of announcement 2022/04/22 Time of announcement 17:22:16
Subject 
 The Board of Directors approved the convening of
the 2022 Annual General Shareholders' Meeting(add new
discussion matters)
Date of events 2022/04/22 To which item it meets paragraph 17
Statement 
1.Date of the board of directors' resolution:2022/04/22
2.Shareholders meeting date:2022/06/17
3.Shareholders meeting location:10F., No. 11, Zhongshan S. Rd.,
Zhongzheng Dist., Taipei City, Taiwan
4.Shareholders meeting will be held by means of (physical shareholders
 meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting):physical shareholders meeting
5.Cause for convening the meeting (1)Reported matters:
(1)The 2021 Business Report.
(2)Audit Committee's review of the Annual Financial Audit Report of
   Year 2021.
(3)For the 2021 Financial Report and the execution status of Sound
   Business Plan.
6.Cause for convening the meeting (2)Acknowledged matters:
(1)To accept 2021 Business Report and Consolidated Financial Report.
(2)To accept proposal of 2021 loss make-up.
7.Cause for convening the meeting (3)Matters for Discussion:
(1)To amend the Operational Procedures for Acquisition and Disposal
   of Assets of the Compnay.
(2)To amend the Rules of Procedure for Shareholders' Meeting of
   the Company.(New matter)
(3)To amend the Company's Memorandum and Articles of Association.
   (New matter)
(4)Proposal for release the prohibition on Directors from participation
   in competitive business.(New matter)
(5)To approve the issuance of 2022 Employees' Restricted Share Awards.
   (New matter)
8.Cause for convening the meeting (4)Election matters:
By-election of one Independent Director of the Company.
9.Cause for convening the meeting (5)Other Proposals:
Proposal for release the prohibition on new Independent Director from
participation in competitive business.(New matter)
10.Cause for convening the meeting (6)Extemporary Motions:None
11.Book closure starting date:2022/04/19
12.Book closure ending date:2022/06/17
13.Any other matters that need to be specified:None

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Tanvex Biopharma Inc. published this content on 22 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 April 2022 09:37:07 UTC.